{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:15:31Z","timestamp":1783577731315,"version":"3.55.0"},"reference-count":74,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Surfactant deficiency underlies several neonatal and pediatric lung diseases, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), and genetic surfactant disorders. Although advances in neonatal care and surfactant replacement therapy have improved survival in preterm infants, current treatments mainly provide supportive management and do not fully address mechanisms of lung injury and impaired lung development. Regenerative approaches based on mesenchymal stromal cells (MSCs) and their extracellular vesicles (EVs) have emerged as potential strategies to promote lung repair and restore alveolar homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This narrative review summarizes experimental and clinical evidence on MSC- and EV-based regenerative strategies for surfactant-related lung diseases. Relevant studies investigating MSCs or MSC-derived EVs in neonatal and pediatric lung injury were identified through searches in PubMed, Scopus and Web of Science and were qualitatively analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main evidence<\/jats:title>\n                    <jats:p>Preclinical studies show that MSCs reduce inflammation, protect type II alveolar epithelial cells and promote alveolar development in models of immature lung injury. These effects are largely mediated by paracrine mechanisms, including the release of MSC-derived EVs, which transfer bioactive molecules to target cells and regulate inflammatory and regenerative pathways. Accordingly, EV-based therapies, as a cell-free derivative of MSCs, reproduce several beneficial effects of MSC transplantation in animal models. Early clinical studies in preterm infants at risk of BPD show encouraging safety profiles, although evidence of long-term efficacy remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>MSC- and EV-based regenerative approaches represent promising strategies for surfactant-related lung diseases. Further studies are needed to clarify mechanisms of action and evaluate their efficacy in well-designed clinical trials involving neonatal and pediatric populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcell.2026.1831705","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:59Z","timestamp":1783575299000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Regenerative strategies for surfactant deficiency in neonatal and pediatric lung disease: the role of mesenchymal stem cells and their extracellular vesicles"],"prefix":"10.3389","volume":"14","author":[{"given":"Gloria","family":"Pelizzo","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Science, University of Milan","place":["Milan, Italy"]},{"name":"Pediatric Surgery Department, Buzzi Children\u2019s Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Calcaterra","sequence":"additional","affiliation":[{"name":"Pediatrics and Adolescentology Unit, Department of Internal Medicine, University of Pavia","place":["Pavia, Italy"]},{"name":"Pediatric Department, Buzzi Children\u2019s Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Avanzini","sequence":"additional","affiliation":[{"name":"Cell Factory and Center for Advanced Therapies, Fondazione IRCCS Policlinico San Matteo","place":["Pavia, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Cordaro","sequence":"additional","affiliation":[{"name":"Pediatric Department, Buzzi Children\u2019s Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Ardenghi","sequence":"additional","affiliation":[{"name":"Pediatric Surgery Department, Buzzi Children\u2019s Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvincenzo","family":"Zuccotti","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Science, University of Milan","place":["Milan, Italy"]},{"name":"Pediatric Department, Buzzi Children\u2019s Hospital","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3349\/ymj.2013.54.2.416","article-title":"Long-term (postnatal day 70) outcome and safe of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury","volume":"54","author":"Ahn","year":"2013","journal-title":"YONSEI Med. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jpeds.2017.02.061","article-title":"Two-year Follow-Up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia","volume":"185","author":"Ahn","year":"2017","journal-title":"J. Pediatr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s12276-018-0055-8","article-title":"Vascular endothelial growth factor mediates the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicles against neonatal hyperoxic lung injury","volume":"50","author":"Ahn","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/sctm.20-0330","article-title":"Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial","volume":"10","author":"Ahn","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/scd.2021.0256","article-title":"Mesenchymal stem cell-derived extracellular vesicles suppress hyperoxia-induced transdifferentiation of rat alveolar type 2 epithelial cells","volume":"31","author":"Ai","year":"2022","journal-title":"Stem Cells Dev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"L770","DOI":"10.1152\/ajplung.00349.2023","article-title":"Mesenchymal stromal cell extracellular vesicles improve lung development in mechanically ventilated preterm lambs","volume":"326","author":"Albertine","year":"2024","journal-title":"Am. J. Physiol-Lung Cell Mol. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1164\/rccm.200902-0242OC","article-title":"Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease","volume":"180","author":"Aslam","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/sctm.17-0126","article-title":"Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies","volume":"6","author":"Augustine","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid\u2010refractory, grade III \u2013 IV acute graft\u2010versus\u2010host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1080\/17476348.2025.2538274","article-title":"Recent advances in the diagnosis and management of pulmonary alveolar proteinosis","volume":"19","author":"Bendstrup","year":"2025","journal-title":"Expert Rev. Respir. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/stcltm\/szab011","article-title":"Comparative effects of bone marrow-derived Versus umbilical cord tissue mesenchymal stem cells in an experimental model of bronchopulmonary dysplasia","volume":"11","author":"Benny","year":"2022","journal-title":"Stem Cells Transl. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/stcltm\/szad070","article-title":"Extracellular vesicles from mesenchymal umbilical cord cells exert protection against oxidative stress and fibrosis in a rat model of bronchopulmonary dysplasia","volume":"13","author":"Bisaccia","year":"2024","journal-title":"Stem Cells Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3727\/096368909X471189","article-title":"Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats","volume":"18","author":"Chang","year":"2009","journal-title":"CELL Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.jpeds.2013.12.011","article-title":"Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial","volume":"164","author":"Chang","year":"2014","journal-title":"J. Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13287-018-0903-4","article-title":"Early gestational mesenchymal stem cell secretome attenuates experimental bronchopulmonary dysplasia in part via exosome-associated factor TSG-6","volume":"9","author":"Chaubey","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13287-017-0634-y","article-title":"Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2174\/011574888X362739250416153254","article-title":"Mitochondria transfer in mesenchymal stem cells: unraveling the mechanism and therapeutic potential","volume":"20","author":"Chen","year":"2025","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e120113","DOI":"10.7363\/120113","article-title":"Bronchopulmonary dysplasia: the more we learn, the less we know","volume":"12","author":"Cical\u00f2","year":"2023","journal-title":"J. Pediatr. Neonatal Individ. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s40746-025-00334-8","article-title":"Recent advances in the management of bronchopulmonary dysplasia","volume":"11","author":"Cosgrove","year":"2025","journal-title":"Curr. Treat. Options Pediatr."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12931-019-1212-x","article-title":"Mesenchymal stromal cell conditioned media for lung disease: a systematic review and meta-analysis of preclinical studies","volume":"20","author":"Emukah","year":"2019","journal-title":"Respir. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"26211","DOI":"10.1074\/jbc.M110.119917","article-title":"Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of Angiopoietin-1","volume":"285","author":"Fang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-196803000-00009","article-title":"Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues","volume":"6","author":"Friedenstein","year":"1968","journal-title":"Transplantation"},{"key":"B24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/978-3-319-08831-0_43","article-title":"Mesenchymal stromal cell secretome for tissue repair","volume-title":"Cell Engineering and Regeneration","author":"Gnecchi","year":"2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/ped.12764","article-title":"Mesenchymal stem cell treatment in hyperoxia-induced lung injury in newborn rats","volume":"58","author":"G\u00fcla\u015f\u0131","year":"2016","journal-title":"Pediatr. Int. Off. J. Jpn. Pediatr. Soc."},{"key":"B26","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1513\/AnnalsATS.201411-507FR","article-title":"The role of surfactant in lung disease and host defense against pulmonary infections","volume":"12","author":"Han","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"B27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/2045-8932.97603","article-title":"Mesenchymal stem cell\u2010mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension","volume":"2","author":"Hansmann","year":"2012","journal-title":"Pulm. Circ."},{"key":"B28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41390-020-0750-8","article-title":"Surfactant replacement therapy: from biological basis to current clinical practice","volume":"88","author":"Hentschel","year":"2020","journal-title":"Pediatr. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e70192","DOI":"10.1002\/mco2.70192","article-title":"Tissue engineering and regenerative medicine: perspectives and challenges","volume":"6","author":"Hoang","year":"2025","journal-title":"MedComm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.paed.2012.09.001","article-title":"The pathophysiology of respiratory distress syndrome in neonates","volume":"22","author":"Holme","year":"2012","journal-title":"Paediatr. Child. Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"jcs260201","DOI":"10.1242\/jcs.260201","article-title":"Extracellular vesicles and nanoparticles at a glance","volume":"137","author":"Jeppesen","year":"2024","journal-title":"J. Cell Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41372-025-02420-z","article-title":"Prophylactic surfactant therapy in the era of less invasive surfactant delivery","volume":"46","author":"Kaluarachchi","year":"2026","journal-title":"J. Perinatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/pr.2017.232","article-title":"Stem cell biology and regenerative medicine for neonatal lung diseases","volume":"83","author":"Kang","year":"2018","journal-title":"Pediatr. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12967-024-05954-6","article-title":"Advancements in lung regeneration: from bench to bedside","volume":"23","author":"Khayatan","year":"2025","journal-title":"J. Transl. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"B36","doi-asserted-by":"publisher","first-page":"4338","DOI":"10.1021\/acs.langmuir.2c03349","article-title":"Surfactant proteins SP-B and SP-C in pulmonary surfactant monolayers: physical properties controlled by specific protein\u2013lipid interactions","volume":"39","author":"Liekkinen","year":"2023","journal-title":"Langmuir"},{"key":"B37","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1055\/a-2001-9139","article-title":"Less invasive surfactant administration: a viewpoint","volume":"41","author":"Mani","year":"2024","journal-title":"Am. J. Perinatol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/B978-1-4557-3383-5.00008-7","article-title":"Alveolar epithelium and pulmonary surfactant","volume-title":"Murray and Nadel\u2019s Textbook of Respiratory Medicine","author":"Mason","year":"2016"},{"key":"B39","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/stcltm\/szac088","article-title":"Prophylactic administration of mesenchymal stromal cells does not prevent arrested lung development in extremely premature-born non-human Primates","volume":"12","author":"M\u00f6bius","year":"2023","journal-title":"Stem Cells Transl. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/sctm.18-0273","article-title":"Intranasal delivery of human umbilical cord Wharton\u2019s jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia","volume":"9","author":"Moreira","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"220188","DOI":"10.1183\/16000617.0188-2022","article-title":"Diagnostic workup of childhood interstitial lung disease","volume":"32","author":"Nathan","year":"2023","journal-title":"Eur. Respir. Rev."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1542\/neo.26-5-014","article-title":"Genetic disorders of surfactant metabolism","volume":"26","author":"Nevel","year":"2025","journal-title":"NeoReviews"},{"key":"B43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ymgme.2009.01.015","article-title":"An overview of pulmonary surfactant in the neonate: Genetics, metabolism, and the role of surfactant in health and disease","volume":"97","author":"Nkadi","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"B44","first-page":"5784146","article-title":"Perinatal hyperoxia and developmental consequences on the lung\u2010brain axis","volume-title":"Oxid Med Cell Longev","author":"Obst","year":"2022"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/diagnostics12122928","article-title":"Genetics in idiopathic pulmonary fibrosis: a clinical perspective","volume":"12","author":"Papiris","year":"2022","journal-title":"Diagnostics"},{"key":"B46","article-title":"Neonatal respiratory distress syndrome","volume-title":"Statpearls","author":"Pattnaik","year":"2026"},{"key":"B47","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.mam.2024.101302","article-title":"Extracellular vesicles transport RNA between cells: unraveling their dual role in diagnostics and therapeutics","volume":"99","author":"Payandeh","year":"2024","journal-title":"Mol. Asp. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.siny.2023.101500","article-title":"Towards personalized therapies for genetic disorders of surfactant dysfunction","volume":"28","author":"Peers","year":"2023","journal-title":"Semin. Fetal Neonatal Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/children10010162","article-title":"Allogeneic mesenchymal stromal cells as a global pediatric prospective approach in the treatment of respiratory failure associated with surfactant protein C dysfunction","volume":"10","author":"Pelizzo","year":"2023","journal-title":"Children"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","article-title":"Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views","volume":"25","author":"Phinney","year":"2007","journal-title":"Stem Cells"},{"key":"B51","doi-asserted-by":"publisher","first-page":"L6","DOI":"10.1152\/ajplung.00109.2018","article-title":"Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia","volume":"316","author":"Porzionato","year":"2019","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"L688","DOI":"10.1152\/ajplung.00148.2020","article-title":"Intratracheal administration of mesenchymal stem cell-derived extracellular vesicles reduces lung injuries in a chronic rat model of bronchopulmonary dysplasia","volume":"320","author":"Porzionato","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1685625","DOI":"10.3389\/fped.2025.1685625","article-title":"A systematic scoping review of the use of surfactant replacement therapy for respiratory distress syndrome in preterm neonates in low- and middle-income countries","volume":"13","author":"Price","year":"2025","journal-title":"Front. Pediatr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"L385","DOI":"10.1152\/ajplung.00389.2022","article-title":"Developmental trajectory of extracellular vesicle characteristics from the lungs of preterm infants","volume":"324","author":"Ransom","year":"2023","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e13831","DOI":"10.14814\/phy2.13831","article-title":"Effects of bone marrow-derived mesenchymal stromal cells on gene expression in human alveolar type II cells exposed to TNF- \u03b1, IL-1 \u03b2, and IFN- \u03b3","volume":"6","author":"Schwede","year":"2018","journal-title":"Physiol. Rep."},{"key":"B56","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1089\/scd.2020.0080","article-title":"Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19","volume":"29","author":"Sengupta","year":"2020","journal-title":"Stem Cells Dev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"101058","DOI":"10.1016\/j.reth.2025.101058","article-title":"Mesenchymal stromal cell\u2013derived extracellular vesicles in regenerative medicine: standardisation, bioengineering and clinical translation","volume":"31","author":"Shimizu","year":"2026","journal-title":"Regen. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/pr.2012.152","article-title":"Long-term reparative effects of mesenchymal stem cell therapy following neonatal hyperoxia-induced lung injury","volume":"73","author":"Sutsko","year":"2013","journal-title":"Pediatr. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000528914","article-title":"European consensus guidelines on the management of respiratory distress syndrome: 2022 update","volume":"120","author":"Sweet","year":"2023","journal-title":"Neonatology"},{"key":"B60","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/stcltm\/szac044","article-title":"Mesenchymal stromal cell mitochondrial transfer as a cell rescue strategy in regenerative medicine: a review of evidence in preclinical models","volume":"11","author":"Tan","year":"2022","journal-title":"Stem Cells Transl. Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"844","DOI":"10.3390\/antiox14070844","article-title":"The destructive cycle in bronchopulmonary dysplasia: the rationale for systems pharmacology therapeutics","volume":"14","author":"Teng","year":"2025","journal-title":"Antioxidants"},{"key":"B62","doi-asserted-by":"publisher","first-page":"250062","DOI":"10.1183\/16000617.0062-2025","article-title":"Old and emerging therapies for childhood interstitial lung disease (chILD): a systematic review","volume":"35","author":"Tonazzo","year":"2026","journal-title":"Eur. Respir. Rev."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1502155","DOI":"10.3389\/fbioe.2024.1502155","article-title":"Innovative approaches in lung tissue engineering: the role of exosome-loaded bioscaffolds in regenerative medicine","volume":"12","author":"Torkashvand","year":"2024","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jare.2024.05.004","article-title":"Mesenchymal stem cell secretome for regenerative medicine: where do we stand?","volume":"70","author":"Trigo","year":"2025","journal-title":"J. Adv. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"L829","DOI":"10.1152\/ajplung.00347.2011","article-title":"Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia","volume":"302","author":"Tropea","year":"2012","journal-title":"Am. J. Physiol-Lung Cell Mol. Physiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1164\/rccm.200902-0179OC","article-title":"Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats","volume":"180","author":"Van Haaften","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"327.5","DOI":"10.1096\/fasebj.31.1_supplement.327.5","article-title":"Mesenchymal stem cell exosome treatment restores lung architecture and ameliorates pulmonary hypertension associated with bronchopulmonary dysplasia","volume":"31","author":"Willis","year":"2017","journal-title":"FASEB J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","article-title":"Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation","volume":"197","author":"Willis","year":"","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B70","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/pr.2017.256","article-title":"\u2018good things come in small packages\u2019: application of exosome-based therapeutics in neonatal lung injury","volume":"83","author":"Willis","year":"","journal-title":"Pediatr. Res."},{"key":"B71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","article-title":"Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial","volume":"3","author":"Wilson","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1089\/scd.2020.0156","article-title":"Human umbilical cord mesenchymal stem cell-derived small extracellular vesicles alleviate lung injury in rat model of bronchopulmonary dysplasia by affecting cell survival and angiogenesis","volume":"29","author":"You","year":"2020","journal-title":"Stem Cells Dev."},{"key":"B73","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1042\/CBI20110447","article-title":"Role of bone marrow-derived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice","volume":"36","author":"Zhang","year":"2012","journal-title":"Cell Biol. Int."},{"key":"B74","doi-asserted-by":"publisher","first-page":"8465294","DOI":"10.1155\/2022\/8465294","article-title":"Microvesicles derived from human umbilical cord mesenchymal stem cells enhance alveolar type II cell proliferation and attenuate lung inflammation in a rat model of bronchopulmonary dysplasia","volume":"2022","author":"Zhou","year":"2022","journal-title":"Stem Cells Int."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1831705\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:35:01Z","timestamp":1783575301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1831705\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":74,"alternative-id":["10.3389\/fcell.2026.1831705"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1831705","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1831705"}}